The world of finance, connected.EN / Global
GS
CompanyCompany profileReviewed 2026-10-23

GSK plc

GSK plc (an abbreviation of its former name GlaxoSmithKline plc) is a British multinational pharmaceutical and biotechnology company. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm. It is headquartered in London, England.

Sources and references ↗
COMPANY PROFILE / 17 SOURCE-LINKED FIELDS

Basic company information

Each field links to its source. Financial figures retain their reporting periods; background references are identified in the source list.

Ticker / security symbols
GSK, GLAXF [1]
Listing exchanges
NYSE, OTC [1]
SEC industry
Pharmaceutical Preparations [1]
Business sectors
pharmaceutical industry; biotechnology [2]
Company / filing name
GSK plc [1]
Headquarters location
London [2]
Business address
79 NEW OXFORD STREET, LONDON, WC1A 1DG [1]
Founded
2000-12-27 [2]
Legal form
public limited company [2]
Incorporation jurisdiction
United Kingdom [1]
Leadership in background record
Emma Walmsley [2]
Official website
www.gsk.com ↗ [2]
Employees
99,300 · reported year 2016 [2]
ISIN (reported securities)
GB0009252882 [2]
CIK
0001131399 [1]
SIC code
2834 [1]
Country in background record
United Kingdom [2]

Company positioning and business

GSK plc (an abbreviation of its former name GlaxoSmithKline plc) is a British multinational pharmaceutical and biotechnology company. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm. It is headquartered in London, England. [3]

GSK is the tenth-largest pharmaceutical company in the world by earnings, $9.32 billion in 2025 with $42.4 billion in revenues in the same period. As of February 2026 it is the 175th most valuable company in the world and the 12th most valuable pharmaceutical company with a market capitalisation of $122.6 billion. It was also ranked 388th on the 2025 Fortune Global 500. [3]

The company has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index, the eighth largest on the London Stock Exchange behind British pharmaceutical rival AstraZeneca, which occupies the No 1 spot in London at a value of $325 billion, 2.7x more than GSK . [3]

Background text: Wikipedia contributors, GSK plc. Selected introductory paragraphs, licensed under CC BY-SA 4.0. Official filing data is cited separately.

Management and corporate governance

The Wikidata background record identifies Emma Walmsley in the chief-executive role. This background entry is not an official confirmation of the current board or executive roster. [2]

Understanding company scale

Employees: 99,300 · reported year 2016. [2]

Financial year, securities and disclosures

Listed securities: GSK (NYSE), GLAXF (OTC). Multiple symbols may represent different share classes or securities of the same registrant. [4]

History and key events

  1. Founding / inception date recorded in Wikidata. [2]

  2. Form 20-F filed; reporting period ends 2025-12-31. [5]

Financial results and regulatory disclosures

Annual, quarterly and current reports from the collected SEC record. Insider Forms 4 and 144 are excluded. This is a selected list, not a live filing feed.

Source-verified relationships

GSK plc → Listed on → NYSE [1]
GSK plc → Listed on → OTC [1]
GSK plc → SEC industry classification → Pharmaceutical Preparations [1]

Companies in the same industry

Comparison candidates share the SEC SIC classification 2834. This does not imply ownership, partnership or trading relationships.

Related entities and concepts

Frequently asked questions

When was GSK plc founded?

Founded: 2000-12-27. The linked source provides the background record. [2]

Where is the headquarters of GSK plc?

Headquarters location: London. The linked source provides the background record. [2]

Which business sectors are recorded for GSK plc?

Business sectors: pharmaceutical industry; biotechnology. The linked source provides the background record. [2]

RELATION MAP

GSK plc relationship map

Drag to rotate · Scroll to zoom
GSK plc

Select a node to inspect its relationship and source.

3 verified direct relationships. Industry peers are not relationship edges.

Sources and review dates

  1. SEC — GSK plc filing identity and securities ↗
  2. Wikidata — company background record (CC0) ↗
  3. Wikipedia contributors — GSK plc (CC BY-SA 4.0) ↗
  4. SEC securities directory ↗
  5. Company chronology / filing ↗

Reviewed 23 October 2026. Financial periods and historical event dates are shown separately. Figures reflect their stated source dates; this page is not a live quote or investment recommendation.

Content preparation: source-based compilation with AI assistance. See methods and attribution. Named sources identify the underlying records; no individual expert review is claimed.